Evidence map›Paper›PMID 30604695›Full record

Observational studyAsian journal of andrology

The current status of hormone treatment for prostate cancer patients in Korean real-world practice: a multi-institutional observational study.

Jung Kwon Kim, Jung Jun Kim, Taek Won Gang, Tae Kyun Kwon, Hong Sup Kim, Seung Chul Park, Jae-Shin Park, Jong-Yeon Park, Seok Joong Yoon, Youn-Soo Jeon and 5 more

Open access · goldAbstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Asian journal of andrology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. [Vasectomy reversal : Literature review].Wiener medizinische Wochenschrift (1946) · 2026
    Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 12 institutions in 1 country.

Jung Kwon KimDepartment of Urology, Seoul National University Bundang Hospital, Seongnam 13620, Korea.
Jung Jun KimDepartment of Urology, Seoul National University Bundang Hospital, Seongnam 13620, Korea.
Taek Won GangDepartment of Urology, Chonnam National University Hospital, Gwangju 61469, Korea.
Tae Kyun KwonSchool of Medicine, Kyungpook National University Medical Center, Daegu 41404, Korea.
Hong Sup KimDepartment of Urology, Konkuk University Medical Center, Seoul 05080, Korea.
Seung Chul ParkDepartment of Urology, Wonkwang University Hospital, Iksan 54538, Korea.
Jae-Shin ParkDepartment of Urology, Daegu Catholic University Medical Center, Daegu 41911, Korea.
Jong-Yeon ParkDepartment of Urology, Ulsan University, Gangneung Asan Hospital, Gangneung 25440, Korea.
Seok Joong YoonDepartment of Urology, Chungbuk National University Hospital, Cheongju 28644, Korea.
Youn-Soo JeonDepartment of Urology, Soonchunhyang University Hospital, Cheonan 31151, Korea.
Jin Seon ChoDepartment of Urology, Hallym University Sacred Heart Hospital, Anyang 14068, Korea.
Kwan Joong JooDepartment of Urology, Kangbuk Samsung Hospital, Seoul 03181, Korea.
Sung-Hoo HongDepartment of Urology, Seoul St. Mary Hospital, Seoul 06591, Korea.
Seok-Soo ByunDepartment of Urology, Seoul National University Bundang Hospital, Seongnam 13620, Korea.
Korean Urological Oncology Society
Seoul National University Bundang Hospital · KRChonnam National University Hospital · KRChungbuk National University Hospital · KRDaegu Catholic University Medical Center · KRGangneung Asan Hospital · KRHallym University Sacred Heart Hospital · KRKangbuk Samsung Hospital · KRKonkuk University Medical Center · KRKyungpook National University Medical Center · KRSoonchunhyang University Hospital Seoul · KRThe Catholic University of Korea Seoul St. Mary's Hospital · KRWonkwang University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We aimed to evaluate the current nationwide trend, efficacy, safety, and quality of life (QoL) profiles of hormone treatment in real-world practice settings for prostate cancer (PCa) patients in Korea. A total of 292 men with any biopsy-proven PCa (TanyNanyMany) from 12 institutions in Korea were included in this multi-institutional, observational study of prospectively collected data. All luteinizing hormone-releasing hormone (LHRH) agonists were allowed to be investigational drugs. Efficacy was defined as (1) the rate of castration (serum testosterone ≤50 ng dl

Indexed as

AgedAndrogen AntagonistsAntineoplastic Agents, HormonalCholesterolDrug Therapy, CombinationHumansLeuprolideMaleMiddle AgedProstatic NeoplasmsQuality of LifeReceptors, LHRHRepublic of KoreaTestosteroneTreatment OutcomeTriglyceridesAndrogen AntagonistsAntineoplastic Agents, HormonalCholesterolLeuprolideReceptors, LHRHTestosteroneTriglyceridesefficacyhormonal treatmentKorean populationprostate cancersafetytrend

Identifiers

PMID30604695
PMCPMC6413546
OpenAlexW2953448950

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.